News

Epiris and Nucleus / HPS /

March 5, 2022

Advised Epiris and Nucleus on the sale of a majority stake in Nucleus to HPS.

We use cookies on our website to deliver a better user experience. By clicking “Accept” you consent to the use of all cookies.